US Activist Hedge Fund Institutional SEC 13D 13G — August 04, 2026

04-08-2026

Pictet Asset Management SA filed an amended Schedule 13D/A disclosing beneficial ownership of 6,357,692 shares of Fortune Brands Innovations, Inc. (FBIN), representing 5.32% of the company's common stock as of July 31, 2026. The shares were acquired for approximately USD 344,224,327.09 on behalf of institutional clients, with sole voting power over 6,112,623 shares. The filing indicates active engagement with the issuer to promote long-term value, but no plans for control or additional acquisitions for control purposes.

• · The filing includes a detailed list of transactions between June 5, 2026 and July 31, 2026, showing both buys and sells of FBIN stock on the NYSE.
• · Pictet Asset Management SA manages the shares on a discretionary basis for institutional clients and does not have any direct economic interest in dividends or sale proceeds.
• · The reporting person has no derivative positions or options related to FBIN securities.
• · The filing states that the reporting person has not been convicted in any criminal proceeding or been party to a civil proceeding involving securities law violations in the last five years.

04-08-2026

Joseph Stilwell and affiliated entities filed a Schedule 13D/A disclosing beneficial ownership of 795,745 shares (17.2%) of Peoples Financial Corp (PFBX) as of July 31, 2026. The filing reports recent open-market purchases: Stilwell Value Partners VII spent $104,391.84 for 4,692 shares and Stilwell Activist Investments spent $1,164,012.44 for 52,918 shares since the last filing. The group continues its activist campaign, including a pending derivative lawsuit seeking compensation for over $50 million in securities portfolio losses, while noting that their director nominees have not been elected in any annual meeting from 2021 through 2026.

• · The Group's director nominees have not been elected at any annual meeting from 2021 through 2026.
• · The Federal Reserve has not objected to the Group purchasing up to 19.9% of PFBX shares.
• · A derivative complaint was filed on September 29, 2023, and the Mississippi Supreme Court denied the directors' interlocutory appeal on April 1, 2025.
• · Stilwell Activist Fund did not purchase or sell any shares in the past sixty days.
• · Shares may be pledged as collateral for margin loans from Morgan Stanley.

04-08-2026

Bruce Bernstein, Chairman of XWELL, Inc., filed a Schedule 13D disclosing beneficial ownership of 602,556 shares (6.9% of the company), including 294,565 shares issuable upon exercise of stock options. On July 6, 2026, Bernstein entered into a Support Agreement to vote his shares in favor of the sale of the Target Companies (XpresSpa and XpresTest) to Express Wellness Group. Bernstein has indicated he may explore extraordinary corporate transactions, but currently has no specific plans for actions such as a merger or change in control.

• · Bernstein's total beneficial ownership is 6.9% of XWELL based on 8,444,266 shares outstanding as of May 14, 2026, plus 294,565 option-exercisable shares.
• · Bernstein serves as Chairman of the Board of Directors and received restricted stock and option compensation awards for his service; no cash was paid for those grants.
• · The Support Agreement was entered into on July 6, 2026, requiring Bernstein to vote all his shares in favor of the sale and against alternative transactions, with transfer restrictions and non-solicitation provisions.
• · Bernstein has no current plans for a merger, change in control, or delisting, but may consider such actions in the future based on market conditions.

04-08-2026

Ximing Huang, CEO of Sharing Economy International Inc. (SEII), filed a Schedule 13D disclosing beneficial ownership of 4,103,939,641 shares of common stock, representing approximately 65.6% of the company's outstanding shares. The shares were acquired on August 2, 2026, pursuant to a Share Exchange Agreement with Light Across, Inc. Mr. Huang has sole voting and dispositive power over all reported shares and states the acquisition was for investment purposes, with no present plans for extraordinary corporate transactions or changes to the board or management.

• · The shares were acquired via a Share Exchange Agreement dated August 2, 2026, among SEII, Light Across, Inc., and Light Across stockholders.
• · Mr. Huang's business address is the same as the issuer's principal executive offices: 9205 Country Club Drive, Farmington Hills, Michigan 48221.
• · Mr. Huang is a U.S. citizen and has not been convicted in any criminal proceeding (excluding traffic violations) during the last five years.
• · No other person has the right to receive dividends or proceeds from the sale of the shares owned by Mr. Huang.
• · Mr. Huang has no present plans or proposals for mergers, asset sales, board changes, delisting, or other extraordinary transactions.

04-08-2026

River Global Investors LLP filed a Schedule 13D disclosing its beneficial ownership of 834,100 shares of MaxCyte, Inc. (MXCT), representing approximately 0.78% of the outstanding common stock. The filing notes that as of July 31, 2026, Liontrust Investment Partners LLP assumed responsibility for certain River Global funds, resulting in the transfer of voting rights on approximately 4.3% of MaxCyte's shares, leaving River Global with the remaining 0.8% stake to be transferred later. The filing also details a series of buy and sell transactions in MaxCyte shares between May and July 2026, with net selling activity during the period.

• · The Schedule 13D was filed in connection with an extraordinary corporate transaction involving the issuer or its subsidiaries, as per an announcement on June 24, 2026 (RNS Number: 4421J).
• · The FCA approved a change in control and proposed acquisition of River Global Holdings Limited.
• · River Global executed multiple trades in MaxCyte shares from May 20, 2026 to July 29, 2026, including purchases of 14,000 shares at $1.0443 and 19,780 shares at $1.0738, and sales totaling over 1 million shares at prices ranging from $0.9879 to $1.13.
• · The net effect of the trades was a reduction in River Global's position from a higher prior level to the current 834,100 shares.

04-08-2026

Chen Xiangdong, founder and CEO of Gaotu Techedu Inc. (GOTU), filed a Schedule 13G/A disclosing beneficial ownership of 82,119,817 ordinary shares (52.4% of outstanding shares) as of June 30, 2026. This stake, held through Ebetter International Group Limited and directly, represents 90.9% of total voting power due to super-voting Class B shares. The filing is a routine ownership update with no change in control or new transactions.

• · The filing is an amendment (Schedule 13G/A) filed on August 4, 2026, with an as-of date of June 30, 2026.
• · Chen Xiangdong's ownership includes 73,305,288 Class B shares (10 votes each) and 3,255,800 Class A shares (1 vote each) held via Ebetter International Group Limited, plus 5,558,729 Class A shares represented by 8,338,094 ADSs held directly.
• · Ebetter International Group Limited is ultimately owned by The Better Learner Trust, a Cayman Islands trust with Cantrust (Far East) Limited as trustee.
• · No changes in ownership percentages or voting power compared to prior filings were noted in the text.

04-08-2026

HUB Cyber Security Ltd. filed a Schedule 13D disclosing beneficial ownership of approximately 9.99% of Evofem Biosciences, Inc. (EVFM) common stock, acquired through purchases of convertible notes and purchase rights. The acquisitions were made through private placements in June and July 2026, paid entirely with HUB equity, not cash. HUB also provided a $706,304 promissory note to Evofem for supplier payments, indicating a strategic investment aimed at expanding into women's health.

• · HUB acquired Evofem Notes and Purchase Rights in exchange for HUB equity securities, not cash.
• · The Evofem Notes bear interest at 8% per annum, compounding monthly, and mature on December 1, 2026, April 8, 2028, and June 26, 2028.
• · The conversion/exercise price for the Evofem Notes and Purchase Rights is $0.0154 per share.
• · HUB's beneficial ownership is limited to 9.99% of Evofem's outstanding common stock due to conversion limitations.
• · Evofem's stockholders approved a reverse stock split of between 1-for-500 and 1-for-1,500, which had not been effectuated as of the filing date.
• · The Promissory Note includes covenants restricting Evofem from certain actions without HUB's consent, such as mergers, asset sales, and bankruptcy filings.

04-08-2026

Farallon Capital Management, L.L.C. and related entities filed a Schedule 13G/A disclosing beneficial ownership of 1,604,590 shares of Assembly Biosciences, Inc. common stock, representing 8.1% of the outstanding shares as of June 30, 2026. The filing also notes that the Farallon Funds hold 510,205 Class A Warrants and 510,205 Class B Warrants, but due to a 4.99% beneficial ownership limitation and the Class B Warrants not being exercisable until November 15, 2026, these warrants are not counted toward current beneficial ownership. No period-over-period comparisons are available as this is an amendment filing without prior period data.

• · The filing is an amendment (Schedule 13G/A) filed on August 4, 2026, with a date of change of August 4, 2026.
• · The beneficial ownership is reported as of June 30, 2026.
• · The Class A Warrants are currently exercisable but subject to a 4.99% beneficial ownership limitation.
• · The Class B Warrants become exercisable on November 15, 2026, also subject to the same limitation.
• · The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

04-08-2026

Richard E. Uihlein filed a Schedule 13D/A with the SEC on August 4, 2026, disclosing beneficial ownership of 54,673,646 shares of Galectin Therapeutics Inc. (GALT), representing approximately 49.3% of the company's common stock. On July 31, 2026, Uihlein converted approximately $105.8 million of debt (including $91.0 million principal and $14.8 million accrued interest) into 34,376,167 shares of common stock, significantly increasing his stake. The filing states the shares were acquired for investment purposes and not to change or influence control of the company.

• · The filing is an amendment (Schedule 13D/A) to a previously filed Schedule 13D.
• · Uihlein's address is 12575 Uline Drive, Pleasant Prairie, WI 53158.
• · The source of funds for the acquisition was personal funds.
• · Uihlein disclaims any purpose or effect of changing or influencing control of the company.

04-08-2026

Farallon Capital Management and related entities filed a Schedule 13G/A disclosing beneficial ownership of 8,365,038 shares of Liquidia Corp common stock as of June 30, 2026, representing a 9.4% stake. The filing is a routine passive ownership disclosure under Rule 13d-1(b), indicating the shares were acquired and are held in the ordinary course of business without intent to change or influence control of the issuer.

• · The filing is an amendment (Schedule 13G/A) to a previously filed Schedule 13G.
• · The shares are held directly by nine Farallon investment partnerships, with Farallon Capital Management acting as investment manager.
• · The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.
• · The filing includes a certification that the securities were acquired and are held in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

04-08-2026

Empery Asset Management, LP and Ryan M. Lane filed a Schedule 13G with the SEC on August 4, 2026, disclosing beneficial ownership of 864,090 shares of Cellectar Biosciences, Inc. common stock (including 674,485 shares issuable upon exercise of warrants), representing 9.99% of the outstanding shares. The filing indicates the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the company.

• · The filing is made under Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business.
• · The warrants contain a blocker provision preventing exercise if it would result in beneficial ownership exceeding 9.99% of outstanding common stock.
• · Empery Asset Management serves as investment manager to the Empery Funds that hold the shares.
• · Ryan M. Lane is the managing member of a limited liability company that is the managing member of Empery AM GP, LLC, the general partner of Empery Asset Management.

04-08-2026

Empery Asset Management, LP and Ryan M. Lane filed a Schedule 13G with the SEC on August 4, 2026, disclosing beneficial ownership of 1,322,551 shares of Lantern Pharma Inc. common stock, representing 9.99% of the outstanding shares as of June 30, 2026. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the company.

• · The filing is made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · The beneficial ownership includes 479,882 shares issuable upon exercise of warrants, subject to a 9.99% blocker provision.
• · The percentage ownership is calculated based on 12,758,872 shares outstanding as of May 31, 2026, as reported in the company's Form S-1 filed on June 12, 2026.
• · Empery Asset Management, LP serves as the investment manager to the Empery Funds that hold the shares.
• · Ryan M. Lane is the managing member of a limited liability company that is the managing member of Empery AM GP, LLC, the general partner of Empery Asset Management, LP.

04-08-2026

Empery Asset Management, LP and Ryan M. Lane filed a Schedule 13G with the SEC on August 4, 2026, disclosing beneficial ownership of 916,532 shares of Clene Inc. common stock, representing a 7.17% stake as of June 30, 2026. The filing is a routine passive ownership disclosure under Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not to influence control of the company.

• · The filing is made under Rule 13d-1(b), confirming the investment manager is a passive investor.
• · Ryan M. Lane is the managing member of a limited liability company that is the managing member of Empery AM GP, LLC, the general partner of Empery Asset Management, LP.
• · The reporting persons disclaim beneficial ownership of shares held by other reporting persons.
• · The total outstanding shares used for percentage calculation is 12,778,307 as of May 11, 2026.

04-08-2026

Medicxi Growth I LP and affiliated entities filed a Schedule 13G/A with the SEC on August 4, 2026, disclosing that as of June 30, 2026, they no longer beneficially own any ordinary shares of Centessa Pharmaceuticals plc. The filing indicates a complete exit of the Medicxi funds from their position in the company.

• · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · The reporting persons include ten affiliated entities, all based in Jersey.
• · The filing is made pursuant to Rule 13d-1(d) under the Securities Exchange Act of 1934.
• · The securities class is Ordinary Shares with a nominal value of £0.002 per share.

04-08-2026

Boston Partners filed an amended Schedule 13G/A with the SEC, disclosing beneficial ownership of 2,470,948 shares of TrueBlue, Inc. common stock as of June 30, 2026, representing 8.13% of the outstanding shares. The shares are held for discretionary client accounts, and Boston Partners disclaims any intent to control or influence the company. This is a routine passive ownership disclosure, with no change in control or acquisition activity.

• · Boston Partners is a Delaware corporation and investment adviser.
• · The filing is an amendment to a prior Schedule 13G, indicating a change in ownership details.
• · Boston Partners disclaims beneficial ownership of any shares beyond the 2,470,948 held for clients.
• · No person has the right to receive or direct dividends or sale proceeds from more than 10% of the outstanding shares.

04-08-2026

Sanders Capital, LLC disclosed a 5.74% beneficial ownership stake in Ulta Beauty, Inc. as of June 30, 2026, holding 2,468,513 shares of common stock. The filing is a routine Schedule 13G under Rule 13d-1(b), indicating passive investment intent, with no change in control or activist purpose. Lewis A. Sanders, CEO and co-Chief Investment Officer of Sanders Capital, is also listed as a beneficial owner due to his ~40% equity interest in the firm.

• · Sanders Capital holds sole voting power over 1,340,077 shares and shared voting power over 2,468,513 shares.
• · The filing is made under Rule 13d-1(b), confirming passive investment intent.
• · Lewis A. Sanders is listed as a beneficial owner due to his ~40% ownership of Sanders Capital and his role as CEO and co-Chief Investment Officer.
• · The filing was signed by Eric Hansen, Deputy Chief Compliance Officer, on August 4, 2026.

04-08-2026

Boston Partners filed a Schedule 13G/A with the SEC on August 4, 2026, disclosing beneficial ownership of 159,450 shares of Proficient Auto Logistics, Inc. common stock, representing 0.57% of the outstanding shares. The filing indicates Boston Partners acquired the shares in the ordinary course of business and not with the purpose of changing or influencing control of the company.

• · The filing is an amendment (Schedule 13G/A) to a prior beneficial ownership report.
• · Boston Partners is a Delaware corporation and an investment adviser (IA).
• · Boston Partners has sole voting power and sole dispositive power over all 159,450 shares.
• · The filing was made pursuant to Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business.
• · The issuer's SEC Central Index Key (CIK) is 0001998768.
• · The filing date is August 4, 2026, with a date as of change of June 30, 2026.

04-08-2026

Copeland Capital Management, LLC filed a Schedule 13G with the SEC on August 4, 2026, disclosing beneficial ownership of 2,016,873 shares of NAPCO SECURITY TECHNOLOGIES, INC (NSSC) common stock, representing a 5.65% stake. The filing indicates the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · Filing date: August 4, 2026; date of event: June 30, 2026.
• · Copeland Capital Management is a Delaware LLC with business address in Conshohocken, PA.
• · The filing is made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · The filer certifies that the securities were not acquired with the purpose of changing or influencing control of the issuer.

04-08-2026

Fiduciary Management Inc. filed a Schedule 13G with the SEC on August 4, 2026, disclosing beneficial ownership of 11,716,529 shares of Hayward Holdings, Inc. common stock, representing a 5.4% stake. The filing indicates the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.

• · Fiduciary Management Inc. holds 10,317,080 shares with sole voting power and 11,716,529 shares with sole dispositive power.
• · The filing is made under Rule 13d-1(b), indicating the investment manager is a passive investor.

04-08-2026

Copeland Capital Management, LLC disclosed a 5.18% beneficial ownership stake in Kforce Inc. (KFRC) as of June 30, 2026, holding 928,350 shares of common stock. The filing was made under Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control. The filing reflects a passive investment by the asset manager.

• · Copeland Capital Management holds sole voting power over 668,434 shares and sole dispositive power over all 928,350 shares.
• · The filing is a Schedule 13G, indicating passive investment intent, not an activist filing (13D).
• · The beneficial ownership is as of the end of the second quarter 2026 (June 30, 2026).

04-08-2026

Copeland Capital Management, LLC filed a Schedule 13G with the SEC on August 4, 2026, disclosing beneficial ownership of 1,973,585 shares of Excelerate Energy, Inc. common stock, representing a 6.20% stake as of June 30, 2026. The filing indicates the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(b), indicating the filer is a passive investor (not seeking control).
• · Copeland Capital Management, LLC is an investment adviser (IA) based in Conshohocken, PA.
• · The filing date is August 4, 2026, with the event date as of June 30, 2026.

04-08-2026

Northwest & Ethical Investments L.P. filed an amended Schedule 13G/A with the SEC, disclosing beneficial ownership of 2,272,670 shares of iShares ESG Advanced MSCI EAFE ETF, representing 15.78% of the outstanding shares as of July 15, 2026. The filing indicates the shares are held with sole voting and dispositive power, and the filer qualifies as an investment fund manager regulated by the Ontario Securities Commission.

• · Filing is an amendment (13G/A) to a prior Schedule 13G.
• · Filer is a Canadian investment fund manager regulated by the Ontario Securities Commission.
• · Filer has sole voting and dispositive power over all 2,272,670 shares.
• · The filing is made under Rule 13d-1(b) of the Securities Exchange Act of 1934.

04-08-2026

Boston Partners filed a Schedule 13G with the SEC on August 4, 2026, disclosing beneficial ownership of 2,595,084 shares of Zebra Technologies Corp common stock, representing 5.45% of outstanding shares as of June 30, 2026. The shares are held for discretionary client accounts, and Boston Partners disclaims any intent to control or influence the company. This is a passive investment disclosure with no change in control or operational impact.

• · Boston Partners is a Delaware corporation, formerly known as Robeco Investment Management, Inc. (name changed 2007-01-11).
• · The filing is made under Rule 13d-1(b), indicating passive investment intent.
• · Boston Partners holds sole voting and dispositive power over 1,789,167 shares; shared power over 0 shares.
• · No person has the right to receive or direct dividends or sale proceeds from more than 5% of the outstanding shares.
• · The shares are held for discretionary accounts of certain clients.

04-08-2026

Logos Global Management LP and affiliated entities filed a Schedule 13G disclosing beneficial ownership of 9.9% of Yarrow Bioscience, Inc. (formerly VYNE Therapeutics Inc.) common stock as of July 27, 2026. The filing reports aggregate holdings of 276,704 shares (including 176,678 common shares and prefunded warrants for 2,201,030 shares) across multiple funds, with all reporting entities subject to a 9.99% beneficial ownership limitation. The filing explicitly states the securities were acquired in the ordinary course of business and not for changing or influencing control of the issuer.

• · The filing is a Schedule 13G (passive investment), not 13D (activist), indicating the holders do not intend to influence control.
• · All reporting persons disclaim membership in a group and beneficial ownership except for their pecuniary interest.
• · The beneficial ownership limitation of 9.99% applies to all holdings, preventing the filers from exceeding that threshold.
• · The issuer changed its name from VYNE Therapeutics Inc. to Yarrow Bioscience, Inc. on September 4, 2020.

04-08-2026

Copeland Capital Management, LLC filed a Schedule 13G/A with the SEC on August 4, 2026, reporting beneficial ownership of 841,544 shares of U.S. Physical Therapy, Inc. (USPH) common stock as of June 30, 2026, representing a 5.53% stake. The filing indicates the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · Copeland Capital Management has sole voting power over 552,857 shares and shared voting power over 128,447 shares.
• · The firm has sole dispositive power over 713,097 shares and shared dispositive power over 128,447 shares.
• · The filing is an amendment (13G/A) to a previous Schedule 13G, indicating a change in ownership or other details since the last filing.

04-08-2026

Streeterville Capital LLC filed a Schedule 13G/A disclosing beneficial ownership of 487,171 shares of Alpha Modus Holdings, Inc. Class A common stock, representing 9.99% of the 4,876,593 shares outstanding as of July 28, 2026. The filing notes that Streeterville has rights under a Securities Purchase Agreement dated June 29, 2026 to own more shares, but is contractually capped at 9.99% ownership. The filing is made jointly by Streeterville Capital LLC, its manager Streeterville Management LLC, and John M. Fife (sole member of the manager).

• · The filing is an amendment (SCHEDULE 13G/A) to a previous Schedule 13G.
• · The ownership cap is contractually set at 9.99%, preventing Streeterville from owning more than that percentage of outstanding shares.
• · The Securities Purchase Agreement was dated June 29, 2026, and includes various Pre-Paid Purchases.
• · The filing was made under Rule 13d-1(c), indicating the shares were not acquired with the purpose of changing or influencing control of the issuer.
• · Streeterville Capital LLC is a Utah limited liability company; Streeterville Management LLC is also a Utah LLC; John M. Fife is a U.S. citizen.

04-08-2026

MMCAP International Inc. SPC and MM Asset Management Inc. filed a Schedule 13G with the SEC on August 4, 2026, disclosing beneficial ownership of 3,450,000 Class A Ordinary Shares of Churchill Capital Corp XIII, representing 9.6% of the outstanding shares. The filing indicates passive investment intent under Rule 13d-1(c), with no aim to change or influence control of the issuer.

• · Filing made under Rule 13d-1(c), indicating passive investment intent.
• · MMCAP International Inc. SPC is organized in the Cayman Islands; MM Asset Management Inc. is organized in Ontario, Canada.
• · The filers disclaim beneficial ownership of any shares beyond the 3,450,000 reported.
• · A joint filing agreement was executed between MMCAP International Inc. SPC and MM Asset Management Inc.

04-08-2026

Northwest & Ethical Investments L.P. filed a Schedule 13G/A with the SEC, disclosing beneficial ownership of 1,320,850 shares of the Avantis Responsible International Equity ETF, a series of American Century ETF Trust. The filing indicates a 22.2% ownership stake as of July 15, 2026, and the filer qualifies as a passive investor under Rule 13d-1(b). No prior period comparison is available in this filing.

• · The filing is an amendment (SCHEDULE 13G/A) to a prior Schedule 13G.
• · The filer is a Canadian investment fund manager regulated by the Ontario Securities Commission.
• · The filer certifies that the foreign regulatory scheme is substantially comparable to the U.S. scheme.
• · No dispositive power is shared; the filer has sole voting and dispositive power over all 1,320,850 shares.

04-08-2026

Vivo Opportunity entities filed a Schedule 13G with the SEC on August 4, 2026, disclosing aggregate beneficial ownership of 11,817,401 ordinary shares (6.9%) of Entera Bio Ltd. The filing follows a private placement on July 28, 2026, in which Entera issued 122,961,215 new ordinary shares, significantly diluting existing shareholders. The Vivo group's holdings are spread across multiple funds, with Vivo Opportunity, LLC deemed the ultimate beneficial owner of the entire stake.

• · The filing is made under Rule 13d-1(c), indicating the securities were not acquired with the purpose of changing or influencing control of Entera Bio.
• · The private placement more than tripled the outstanding share count from 49,290,196 to 172,251,411 shares.
• · Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity Co-Invest, L.P., and Vivo Opportunity Co-Invest (Cycle 3), L.P.

04-08-2026

Van Berkom & Associates Inc. filed a Schedule 13G with the SEC on August 4, 2026, disclosing beneficial ownership of 2,969,220 common shares of Stevanato Group S.p.A. (STVN), representing 5.97% of the outstanding shares. The filing indicates the shares were acquired in the ordinary course of business and not with the intent to change or influence control of the issuer.

• · Van Berkom & Associates Inc. is a Canadian investment adviser filing under Rule 13d-1(b).
• · The reporting person has sole voting and sole dispositive power over all 2,969,220 shares.
• · The filing date is August 4, 2026, with the event date of June 30, 2026.

04-08-2026

Alpha Capital Anstalt filed a Schedule 13G/A disclosing beneficial ownership of 559,394 common shares of Fabric.AI, Inc. (formerly StableX Technologies, Inc.), representing 8.41% of outstanding shares as of June 30, 2026. The filing reflects a passive investment posture, with the filer certifying the shares were not acquired to change or influence control.

• · Fabric.AI, Inc. changed its name from StableX Technologies, Inc. on August 26, 2025.
• · Alpha Capital Anstalt operates under a 4.99% and 9.99% contractual ownership restriction, limiting the maximum reported beneficial ownership to 559,394 shares.
• · The filing is an amendment (Schedule 13G/A) and was made under Rule 13d-1(c).
• · Fabric.AI's business address is 1185 Avenue of the Americas, New York, NY 10036.

04-08-2026

Wearable Devices Ltd. faces a legal challenge from its largest shareholder group, led by Daniel Nissim and J.B.D Innovation Ltd., who obtained a temporary injunction from an Israeli court to block a proposed $3.285 million private placement. The shareholders argue the placement would improperly alter capital structure and voting dynamics, while the company defends it as a market-priced financing needed for operations. The injunction temporarily halts the placement pending a hearing on August 16, 2026.

• · The temporary injunction was issued ex parte by the Economic Department of the District Court of Haifa, Israel, on August 2, 2026, and prohibits the Issuer from advancing the Private Placement or modifying its capital structure pending further order.
• · A hearing is scheduled for August 16, 2026.
• · The Reporting Persons previously filed a demand for a special meeting of shareholders, and the Private Placement is alleged to affect matters that may be considered at that meeting.
• · The Issuer rejected the shareholders' objections, stating the Private Placement was market-priced and needed to fund operations and growth.
• · The Reporting Persons collectively own 381,361 Ordinary Shares, representing 17.42% of the outstanding shares.

04-08-2026

CD&R entities filed an amended Schedule 13D disclosing a 19.7% beneficial ownership stake in Resideo Technologies following the ADI spin-off. In connection with the spin-off, CD&R exchanged 149,550 preferred shares for ADI preferred stock, extended its lock-up period to August 3, 2028, and designated Andrew Campelli to the board. The filing reflects a significant ongoing relationship with the sponsor, including amended conversion terms and registration rights.

• · The ADI spin-off was completed on August 3, 2026, distributing 100% of ADI common stock to Resideo shareholders on a pro rata basis, intended to be tax-free.
• · The lock-up period for CD&R stockholders was extended to August 3, 2028, covering all common shares owned by them after the spin-off.
• · Nathan K. Sleeper resigned from the board effective upon the ADI spin-off; Andrew Campelli was designated to fill the vacancy.
• · The amended certificate of designations adjusted the preferred stock conversion price from $26.92 to $18.844 and modified the issuer's redemption/conversion rights to be exercisable only after lock-up expiration.
• · CD&R Holdings II was joined to the Investment Agreement and Registration Rights Agreement as part of the amendments.

04-08-2026

Boston Partners filed a Schedule 13G/A with the SEC on August 4, 2026, disclosing beneficial ownership of 11,992,504.2 shares of Range Resources Corp common stock as of June 30, 2026, representing a 5.09% stake. The filing indicates that Boston Partners holds these shares for the discretionary accounts of certain clients and that the securities were acquired in the ordinary course of business, not with the intent to change or influence control of the issuer.

• · Boston Partners has sole voting power over 8,462,461 shares and sole dispositive power over all 11,992,504.2 shares.
• · The filing is an amendment (Schedule 13G/A) to a previous Schedule 13G.
• · Boston Partners is organized under the laws of Delaware and its business address is One Beacon Street, 30th Floor, Boston, Massachusetts 02108.

04-08-2026

Laurion Capital Management LP has filed a Schedule 13G/A with the SEC, disclosing that it and its principals (Benjamin Alexander Smith and Janaka Sheehan Maduraperuma) collectively own 0 shares of Rallybio Corp common stock as of June 30, 2026. This indicates the funds advised by Laurion Capital have completely exited their position in Rallybio Corp.

• · Filing is an amendment (Schedule 13G/A), indicating a change from a prior filing.
• · Laurion Capital Management LP is an investment adviser filing under Rule 13d-1(b), so the prior stake was likely above 5% and has now been reduced to zero.
• · No other funds or entities are reported as holding shares on behalf of Laurion Capital.
• · The reporting persons certify the shares were held in the ordinary course of business and not to influence control of the issuer.

04-08-2026

Stephen J. Barnard, a director and/or officer of Mission Produce, Inc., filed a Schedule 13G/A disclosing beneficial ownership of 5,504,961 shares of common stock as of June 30, 2026, representing 6.2% of the outstanding shares. The filing updates his prior beneficial ownership report and details holdings across direct shares, vested options, and shares held by family trusts and an LLC.

• · The filing is an amendment (Schedule 13G/A) to a prior beneficial ownership report.
• · Mr. Barnard disclaims beneficial ownership of shares held by Barnard Properties, LLC, Shelly R. Barnard GT Trust, and Stephen J. Barnard GT Trust, except to the extent of any pecuniary interest.
• · Mr. Barnard and his spouse share voting and dispositive power over the shares held by the LLC and trusts.
• · The total outstanding share count used for the percentage calculation includes 1,699,770 shares subject to options exercisable within 60 days.

04-08-2026

FMR LLC and Abigail P. Johnson filed Amendment No. 22 to their Schedule 13D, disclosing that as of July 31, 2026, they directly own 3,070,730.635 common shares of Fidelity Multi-Strategy Credit Fund, representing 53.481% of the outstanding shares. The filing reports recent acquisitions of 54,603.53 shares through the Dividend Reinvestment Plan (DRP), including purchases on June 30, 2026, at $10.39 per share. This is a routine beneficial ownership update with no change in control or strategic actions.

• · The filing is Amendment No. 22 to the original Schedule 13D filed on May 26, 2023.
• · On June 30, 2026, FMR Reporters acquired shares in four classes: Class A (49.968 shares), Class C (41.447 shares), Class I (13,053.887 shares), and Class L (47.086 shares), all at $10.39 per share.
• · FMR Reporters hold sole power to vote and dispose of all 3,070,730.635 shares.
• · No other person has the right to receive dividends or proceeds from the sale of these securities.

04-08-2026

Bigger Capital Fund, L.P. and related entities filed a Schedule 13G/A with the SEC on August 4, 2026, disclosing their aggregate beneficial ownership of ClearPoint Neuro, Inc. common stock. Michael Bigger is deemed to beneficially own approximately 7.45% of the outstanding shares (2,272,980 shares), while Bigger Capital Fund directly owns 1,405,284 shares (4.60%). The filing indicates no change in control intent, as the securities were not acquired for the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (SC 13G/A) to a previously filed Schedule 13G.
• · The securities were acquired under Rule 13d-1(c), indicating passive investment intent.
• · Michael Bigger disclaims beneficial ownership of shares held by Patricia Winter and his sons, as well as shares owned by the entities.
• · The filing date is August 4, 2026, with the event date as of change also August 4, 2026.
• · ClearPoint Neuro, Inc. is incorporated in Delaware and has its business address at 120 S. Sierra Avenue, Suite 100, Solana Beach, CA 92075.

04-08-2026

PSM Holdings LLC disclosed a 8.6% beneficial ownership stake in Prairie Operating Co. (PROP) as of August 3, 2026, holding 8,392,740 shares of common stock. The filing was made under Rule 13d-1(c) and certifies that the shares were not acquired with the purpose of changing or influencing control of the issuer. The ultimate beneficial owner is Edgar Anthony Martinez, Managing Director of PSM Holdings.

• · The filing was made under Rule 13d-1(c), indicating passive investment intent.
• · PSM Holdings LLC is a Delaware limited liability company.
• · The issuer's common stock has a par value of $0.01 per share.
• · Prairie Operating Co. was formerly known as Creek Road Miners, Inc. (name change July 2021), WIZARD BRANDS, INC. (name change August 2020), and WIZARD ENTERTAINMENT, INC. (name change October 2018).
• · The filing certifies that the securities were not acquired with the purpose of changing or influencing control.

04-08-2026

Jane Street Group, LLC disclosed a 5.1% beneficial ownership stake in Bloom Energy Corp as of July 29, 2026, holding 14,874,272.16 shares of common stock. The filing is a Schedule 13G under Rule 13d-1(c), indicating the securities were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

• · Jane Street Capital, LLC holds 10,712,665.16 shares (3.6%), Jane Street Global Trading, LLC holds 2,004,682.00 shares (0.7%), Leonard Street Holdings, LP holds 2,156,837.00 shares (0.7%), and Jane Street Singapore Pte. Ltd holds 88 shares (0.0%).
• · The filing is a Schedule 13G, not a 13D, indicating passive investment intent.
• · The securities were acquired as of July 29, 2026, and the filing was made on August 4, 2026.

04-08-2026

Boston Partners disclosed a 5.31% beneficial ownership stake in Methanex Corp, holding 4,110,146.27 common shares as of June 30, 2026. The filing is a Schedule 13G, indicating passive investment intent, and Boston Partners disclaims beneficial ownership of dividends or proceeds for clients.

• · Boston Partners is a Delaware corporation and investment adviser.
• · The shares are held for discretionary accounts of certain clients.
• · Boston Partners certifies that the securities were acquired in the ordinary course of business and not to change or influence control.
• · The filing is made pursuant to Rule 13d-1(b).

04-08-2026

Eleftherios Papatrifon filed a final Schedule 13D/A (Amendment No. 18) with the SEC on August 4, 2026, reporting that as of July 31, 2026, he ceased to be a beneficial owner of more than 5% of OceanPal Inc. common stock. This exit filing follows his sale of all Series D Preferred Stock to the issuer in December 2025 and the transfer of all Series C Preferred Stock for cancellation on July 31, 2026. Papatrifon retains 23,529 common shares (1.25% of outstanding shares) and remains a board member and executive committee member.

• · The reporting person sold all Series D Preferred Stock to the issuer on December 1, 2025, pursuant to a promissory note.
• · All Series C Preferred Stock was transferred to the issuer for cancellation on July 31, 2026.
• · This is the 18th amendment to the original Schedule 13D filed on June 26, 2024, and is designated as the final exit filing.
• · Papatrifon retains sole voting power over his 23,529 common shares.

04-08-2026

Boston Partners filed a Schedule 13G with the SEC, disclosing beneficial ownership of 4,004,971.61 shares of LPL Financial Holdings Inc. common stock as of June 30, 2026, representing 5.01% of outstanding shares. The shares are held for discretionary client accounts, and the filing indicates the position was acquired in the ordinary course of business without intent to influence control. This is a passive ownership disclosure, not an acquisition or regulatory action.

• · Boston Partners is a Delaware corporation and an investment adviser (IA).
• · The filing is made under Rule 13d-1(b) of the Securities Exchange Act of 1934.
• · Boston Partners has sole voting power over 3,306,027 shares and sole dispositive power over 4,004,971.61 shares.
• · Boston Partners disclaims beneficial ownership of the shares held for client accounts.
• · The filing was submitted on August 4, 2026, with the ownership date as of June 30, 2026.